Results 121 to 130 of about 41,522 (262)
Overuse of inhaled corticosteroids in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease: Observational real-life data. [PDF]
Arslan Aksu E +8 more
europepmc +1 more source
Summary Background and objectives Oral lichen planus (OLP) is a chronic autoimmune mucosal disease with malignant potential and limited treatment options. This study evaluated the long‐term efficacy and safety of cold atmospheric plasma (CAP) therapy in therapy‐refractory OLP and introduced the novel Lichen Planus Severity Score (LPSS).
Christian Seebauer +5 more
wiley +1 more source
The role of COPD and inhaled corticosteroids in major adverse cardiovascular events in cardiovascular-kidney-metabolic populations. [PDF]
Ioannides AE +5 more
europepmc +1 more source
ABSTRACT Aim To provide a practical guide on when to suspect endogenous hypercortisolism, how to use the overnight 1‐mg dexamethasone suppression test (DST) for targeted case‐finding, and which patients are most likely to benefit from treatment.
Juan Pablo Frias
wiley +1 more source
The Hidden Cost of Asthma Control: Esophageal Candidiasis Induced by Inhaled Corticosteroids. [PDF]
Miqdadi A +5 more
europepmc +1 more source
Abstract The landscape of asthma management is undergoing significant transformation. This change is driven by several factors: deeper understanding of asthma pathophysiology, appreciation of the long‐term harm of oral corticosteroids, biological treatments that dramatically improve patient outcomes with asthma remission becoming a realistic goal, and ...
John Politis +4 more
wiley +1 more source
Applying High-Dimensional Propensity Scores in a Study of Inhaled Corticosteroids and COVID-19 Outcomes. [PDF]
Bokern M +5 more
europepmc +1 more source
Age-related differences in adherence to inhaled corticosteroids among adult patients with asthma: a national cohort study in South Korea. [PDF]
Park HS, Lee J, Kim H, Woo SD.
europepmc +1 more source
Before and beyond Inhaled Corticosteroids
openaire +2 more sources

